These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9922778)

  • 1. [Concomitant chemoradiotherapy of infiltrating cancers of the bladder].
    Housset M
    Cancer Radiother; 1998 Dec; 2(6):713-7. PubMed ID: 9922778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concurrent radio-chemotherapy in infiltrating cancer of the bladder: a new therapeutic approach?].
    Housset M; Dufour B; Durdux C; Chrétien Y; Méjean A; Baillet F
    Cancer Radiother; 1998 Apr; 2 Suppl 1():67s-72s. PubMed ID: 9749082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
    Pansadoro V; Emiliozzi P
    Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy preceding cystectomy for bladder cancer.
    Sonpavde G; Amiel GE; Mims MP; Hayes TG; Lerner SP
    Expert Opin Pharmacother; 2008 Aug; 9(11):1885-93. PubMed ID: 18627327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Meta-analysis of neoadjuvant chemotherapy in locally advanced bladder cancer].
    Ruggeri EM
    Suppl Tumori; 2004; 3(4):S55-6. PubMed ID: 15206213
    [No Abstract]   [Full Text] [Related]  

  • 7. Trimodality treatment in the conservative management of infiltrating bladder cancer: a critical review of the literature.
    Caffo O; Veccia A; Fellin G; Russo L; Mussari S; Galligioni E
    Crit Rev Oncol Hematol; 2013 May; 86(2):176-90. PubMed ID: 23088957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is there an indication for adjuvant or neoadjuvant systemic chemotherapy in bladder cancer?].
    Suttmann H; Retz M; Gschwend JE; Stöckle M
    Urologe A; 2007 Oct; 46(10):1379-80, 1382-4. PubMed ID: 17805506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemoradiotherapy of carcinomas of the upper aerodigestive tract].
    Bourhis J; Calais G; Eschwège F
    Cancer Radiother; 1998 Dec; 2(6):679-88. PubMed ID: 9922773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer.
    Sauer R; Birkenhake S; Kühn R; Wittekind C; Schrott KM; Martus P
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):121-7. PubMed ID: 9422567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.
    Hagan MP; Winter KA; Kaufman DS; Wajsman Z; Zietman AL; Heney NM; Toonkel LM; Jones CU; Roberts JD; Shipley WU
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):665-72. PubMed ID: 14529770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan.
    Matsui Y; Nishiyama H; Watanabe J; Teramukai S; Ono Y; Ohshima S; Fujimoto K; Hirao Y; Fukushima M; Ogawa O
    Int J Clin Oncol; 2005 Apr; 10(2):133-8. PubMed ID: 15864700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy for bladder cancer.
    Sonpavde G; Lerner SP
    Oncology (Williston Park); 2007 Dec; 21(14):1673-81; discussion 1686-8, 1691, 1694. PubMed ID: 18247016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
    Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
    Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neoadjuvant chemotherapy: meta-analysis and interpretation of results in bladder cancer].
    Pollera CF
    Suppl Tumori; 2004; 3(4):S59-61. PubMed ID: 15206215
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemoradiotherapy as a bladder-preservation approach for muscle-invasive bladder cancer: current status and perspectives.
    Sumiyoshi Y
    Int J Clin Oncol; 2004 Dec; 9(6):484-90. PubMed ID: 15616879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
    Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cT2 bladder cancer: a good candidate for radiotherapy combined with cisplatin for bladder preservation.
    Hara T; Nishijima J; Miyachika Y; Yamamoto Y; Sakano S; Matsuyama H
    Jpn J Clin Oncol; 2011 Jul; 41(7):902-7. PubMed ID: 21616918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Respective roles of radiotherapy and chemotherapy in adjuvant treatment of cancer of the breast: theoretical importance and feasibility of chemoradiotherapy].
    Freyer G; Romestaing P
    Cancer Radiother; 1998 Dec; 2(6):723-31. PubMed ID: 9922780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current role of chemotherapy in the treatment of invasive cancers of the bladder].
    Chauvet B; Davin JL; Vincent P; Alfonsi M; Serin D; Levallois M; Reboul F
    Bull Cancer; 1992; 79(3):279-90. PubMed ID: 1392167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.